EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Temporal changes in lipoprotein(a) after acute coronary syndrome

Christelle Lattouf, Mark Atallah, Nadim Nasrallah, Tarek Harb, Gary Gerstenblith, Thorsten M Leucker

American Journal of Preventive Cardiology · 2027-01 · 31 · 101723

DOI: 10.1016/j.ajpc.2026.101723 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Preventive Cardiology, 2027-01. Verfasst von Christelle Lattouf und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Novartis Pharmaceuticals Corporation, Novartis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims: Lipoprotein(a) [Lp(a)] is an established independent risk factor for atherosclerotic cardiovascular disease and is traditionally considered stable. Its behavior following acute coronary syndrome (ACS) and clinical implications remain unclear. This study aimed to characterize the temporal trajectory of Lp(a) following ACS, evaluate whether baseline levels predict longitudinal changes, and assess the stability of clinically relevant Lp(a) risk categories. Methods: In this prospective study, 225 patients with ACS underwent serial Lp(a) measurements during hospitalization and at follow-up (≥6 months). Longitudinal changes were assessed using linear mixed-effects models. Associations between baseline Lp(a) and changes over time were evaluated using Spearman correlation. Stability of Lp(a) threshold risk categories (

Schlagwörter

Stichwörter der Autor:innen

Acute coronary syndromeBiomarkersLipoprotein(a)Myocardial infarctionRisk stratificationTrajectory

Autor:innen und Institutionen

  • Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Förderung

  • Novartis Pharmaceuticals Corporation
  • Novartis

Zitieren

APA

Lattouf, C., Atallah, M., Nasrallah, N., Harb, T., Gerstenblith, G., & Leucker, T. M. (2027). Temporal changes in lipoprotein(a) after acute coronary syndrome. American Journal of Preventive Cardiology, 31, 101723. https://doi.org/10.1016/j.ajpc.2026.101723

Vancouver

Lattouf C, Atallah M, Nasrallah N, Harb T, Gerstenblith G, Leucker TM. Temporal changes in lipoprotein(a) after acute coronary syndrome. American Journal of Preventive Cardiology. 2027;31:101723. doi:10.1016/j.ajpc.2026.101723

BibTeX
@article{Lattouf2027,
  author = {Lattouf, Christelle and Atallah, Mark and Nasrallah, Nadim and Harb, Tarek and Gerstenblith, Gary and Leucker, Thorsten M},
  title = {Temporal changes in lipoprotein(a) after acute coronary syndrome},
  journal = {American Journal of Preventive Cardiology},
  year = {2027},
  volume = {31},
  pages = {101723},
  doi = {10.1016/j.ajpc.2026.101723}
}
Kostenlos starten →